240 related articles for article (PubMed ID: 7685989)
21. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
Rubin J; Chung LW; Fan X; Zhu L; Murphy TC; Nanes MS; Rosen CJ
Prostate; 2004 Jan; 58(1):41-9. PubMed ID: 14673951
[TBL] [Abstract][Full Text] [Related]
22. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
[TBL] [Abstract][Full Text] [Related]
23. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells.
Conover CA; Bale LK; Clarkson JT; Tørring O
Endocrinology; 1993 Jun; 132(6):2525-30. PubMed ID: 7684979
[TBL] [Abstract][Full Text] [Related]
24. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells.
Rabbani SA; Desjardins J; Bell AW; Banville D; Mazar A; Henkin J; Goltzman D
Biochem Biophys Res Commun; 1990 Dec; 173(3):1058-64. PubMed ID: 2125213
[TBL] [Abstract][Full Text] [Related]
25. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer.
Koutsilieris M; Sourla A; Pelletier G; Doillon CJ
J Bone Miner Res; 1994 Nov; 9(11):1823-32. PubMed ID: 7863832
[TBL] [Abstract][Full Text] [Related]
27. Identification, localization, and regulation of insulin-like growth factor binding proteins and their messenger ribonucleic acids in the newborn rat olfactory bulb.
Russo VC; Edmondson SR; Mercuri FA; Buchanan CR; Werther GA
Endocrinology; 1994 Oct; 135(4):1437-46. PubMed ID: 7523098
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
29. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.
Ernst M; Rodan GA
Endocrinology; 1990 Aug; 127(2):807-14. PubMed ID: 2164921
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor.
Tranque P; Naftolin F; Robbins R
Endocrinology; 1994 Jun; 134(6):2606-13. PubMed ID: 8194486
[TBL] [Abstract][Full Text] [Related]
31. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-beta and retinoic acid.
Menouny M; Binoux M; Babajko S
Endocrinology; 1997 Feb; 138(2):683-90. PubMed ID: 9003003
[TBL] [Abstract][Full Text] [Related]
32. Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin.
Bradshaw SL; Han VK
Endocrinology; 1993 Oct; 133(4):1767-77. PubMed ID: 7691580
[TBL] [Abstract][Full Text] [Related]
33. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
34. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.
Burfeind P; Chernicky CL; Rininsland F; Ilan J; Ilan J
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7263-8. PubMed ID: 8692980
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
36. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line.
Cheung PT; Wu J; Banach W; Chernausek SD
Endocrinology; 1994 Oct; 135(4):1328-35. PubMed ID: 7523095
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
[TBL] [Abstract][Full Text] [Related]
39. Development of specific antibodies to rat insulin-like growth factor-binding proteins (IGFBP-2 to -6): analysis of IGFBP production by rat granulosa cells.
Liu XJ; Malkowski M; Guo Y; Erickson GF; Shimasaki S; Ling N
Endocrinology; 1993 Mar; 132(3):1176-83. PubMed ID: 7679972
[TBL] [Abstract][Full Text] [Related]
40. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
Paciucci R; Vilá MR; Adell T; Díaz VM; Torà M; Nakamura T; Real FX
Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
